
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani, John Olds
Molecular Pharmacology (2020) Vol. 97, Iss. 5, pp. 351-353
Open Access | Times Cited: 134
Nadine Kabbani, John Olds
Molecular Pharmacology (2020) Vol. 97, Iss. 5, pp. 351-353
Open Access | Times Cited: 134
Showing 26-50 of 134 citing articles:
Nicotine and the nicotinic cholinergic system in COVID‐19
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3656-3663
Open Access | Times Cited: 60
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3656-3663
Open Access | Times Cited: 60
The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury
Kai E. Swenson, Stephen J. Ruoss, Erik R. Swenson
Annals of the American Thoracic Society (2021) Vol. 18, Iss. 7, pp. 1098-1105
Open Access | Times Cited: 53
Kai E. Swenson, Stephen J. Ruoss, Erik R. Swenson
Annals of the American Thoracic Society (2021) Vol. 18, Iss. 7, pp. 1098-1105
Open Access | Times Cited: 53
Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
Kuo‐Yen Huang, M. L. Lin, Ting‐Chun Kuo, et al.
EMBO Molecular Medicine (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 51
Kuo‐Yen Huang, M. L. Lin, Ting‐Chun Kuo, et al.
EMBO Molecular Medicine (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 51
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 9, pp. 666-695
Open Access | Times Cited: 38
Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 9, pp. 666-695
Open Access | Times Cited: 38
Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19
Mahsa Aghajani Mir
Molecular Neurobiology (2023) Vol. 61, Iss. 12, pp. 9915-9926
Closed Access | Times Cited: 22
Mahsa Aghajani Mir
Molecular Neurobiology (2023) Vol. 61, Iss. 12, pp. 9915-9926
Closed Access | Times Cited: 22
Inflammation-related pathology in the olfactory epithelium: its impact on the olfactory system in psychotic disorders
Kun Yang, Yuto Hasegawa, Janardhan P. Bhattarai, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1453-1464
Open Access | Times Cited: 7
Kun Yang, Yuto Hasegawa, Janardhan P. Bhattarai, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1453-1464
Open Access | Times Cited: 7
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Vladimir N. Uversky, Fatma Elrashdy, Abdullah A. Aljadawi, et al.
Journal of Neuroscience Research (2020) Vol. 99, Iss. 3, pp. 750-777
Open Access | Times Cited: 50
Vladimir N. Uversky, Fatma Elrashdy, Abdullah A. Aljadawi, et al.
Journal of Neuroscience Research (2020) Vol. 99, Iss. 3, pp. 750-777
Open Access | Times Cited: 50
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Alejandro Romero, Eva Ramos, Francisco López‐Muñoz, et al.
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 3, pp. 489-500
Open Access | Times Cited: 42
Alejandro Romero, Eva Ramos, Francisco López‐Muñoz, et al.
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 3, pp. 489-500
Open Access | Times Cited: 42
Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Lyubka Tancheva, Maria Cristina Petralia, Simona Miteva, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 852-852
Open Access | Times Cited: 41
Lyubka Tancheva, Maria Cristina Petralia, Simona Miteva, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 852-852
Open Access | Times Cited: 41
The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4178-4187
Open Access | Times Cited: 41
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4178-4187
Open Access | Times Cited: 41
Anosmia and ageusia associated with coronavirus infection (COVID‑19) - what is known?
Ingrid-Andrada Vasilache, Carmen Manciuc, Alexandru Cărăuleanu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 40
Ingrid-Andrada Vasilache, Carmen Manciuc, Alexandru Cărăuleanu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 40
Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations
Lucia A. Méndez‐García, Galileo Escobedo, Alan Gerardo Minguer-Uribe, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Lucia A. Méndez‐García, Galileo Escobedo, Alan Gerardo Minguer-Uribe, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2
Gauthier Duloquin, Thibaut Pommier, Marjolaine Georges, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 6
Gauthier Duloquin, Thibaut Pommier, Marjolaine Georges, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 6
Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 2, pp. 479-503
Closed Access | Times Cited: 36
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
Noemí Cárdenas‐Rodríguez, Cindy Bandala, América Vanoye‐Carlo, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 971-971
Open Access | Times Cited: 32
Noemí Cárdenas‐Rodríguez, Cindy Bandala, América Vanoye‐Carlo, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 971-971
Open Access | Times Cited: 32
Neurological manifestations of COVID-19: A systematic review
Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, et al.
Research Square (Research Square) (2020)
Closed Access | Times Cited: 31
Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, et al.
Research Square (Research Square) (2020)
Closed Access | Times Cited: 31
Acute and long-term neurological manifestations of Covid-19: insights from virology and neurology
Kirolos Eskandar
Deleted Journal (2025) Vol. 16, Iss. 1, pp. 3-13
Closed Access
Kirolos Eskandar
Deleted Journal (2025) Vol. 16, Iss. 1, pp. 3-13
Closed Access
Implications of Tobacco Use on Pathogen‐Driven Diseases: A Public Health and Policy Perspective
Nadine Kabbani, John Olds
World Medical & Health Policy (2025)
Open Access
Nadine Kabbani, John Olds
World Medical & Health Policy (2025)
Open Access
Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection
Francesca Galluzzi, Verónica Rossi, Cristina Bosetti, et al.
Neuroepidemiology (2021) Vol. 55, Iss. 2, pp. 154-161
Closed Access | Times Cited: 22
Francesca Galluzzi, Verónica Rossi, Cristina Bosetti, et al.
Neuroepidemiology (2021) Vol. 55, Iss. 2, pp. 154-161
Closed Access | Times Cited: 22
Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
Smriti Sinha, Swati Mittal, Rupali Roy
Journal of Movement Disorders (2021) Vol. 14, Iss. 3, pp. 184-192
Open Access | Times Cited: 21
Smriti Sinha, Swati Mittal, Rupali Roy
Journal of Movement Disorders (2021) Vol. 14, Iss. 3, pp. 184-192
Open Access | Times Cited: 21
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview
Sivan Padma Priya, Priyanka Sunil, Sudhir Varma, et al.
VirusDisease (2022) Vol. 33, Iss. 4, pp. 429-444
Open Access | Times Cited: 16
Sivan Padma Priya, Priyanka Sunil, Sudhir Varma, et al.
VirusDisease (2022) Vol. 33, Iss. 4, pp. 429-444
Open Access | Times Cited: 16
Anosmia in COVID-19 patients
Daniel Hornuß, Berit Lange, Nils Schröter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 22
Daniel Hornuß, Berit Lange, Nils Schröter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 22
Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
Anjing Chen, Wenguo Zhao, Xiaolong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Anjing Chen, Wenguo Zhao, Xiaolong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review
Gehan A. Pendlebury, Peter Oro, William Haynes, et al.
Dermatopathology (2022) Vol. 9, Iss. 3, pp. 212-243
Open Access | Times Cited: 13
Gehan A. Pendlebury, Peter Oro, William Haynes, et al.
Dermatopathology (2022) Vol. 9, Iss. 3, pp. 212-243
Open Access | Times Cited: 13
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
Peter Riederer, Volker ter Meulen
Journal of Neural Transmission (2020) Vol. 127, Iss. 9, pp. 1217-1228
Open Access | Times Cited: 20
Peter Riederer, Volker ter Meulen
Journal of Neural Transmission (2020) Vol. 127, Iss. 9, pp. 1217-1228
Open Access | Times Cited: 20